Nova Eye Medical Ltd
ASX:EYE
Nova Eye Medical Ltd
ASX:EYE
Price:
0.165
AUD
Market Closed
Market Cap:
AU$47m
Income Statement
Earnings Waterfall
Nova Eye Medical Ltd
Nova Eye Medical Ltd
Income Statement
Nova Eye Medical Ltd
Nova Eye Medical Ltd
Currency: AUD
| Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
16
N/A
|
16
-3%
|
13
-19%
|
12
-5%
|
14
+12%
|
14
0%
|
13
-1%
|
15
+12%
|
17
+14%
|
19
+9%
|
23
+25%
|
26
+12%
|
29
+12%
|
|
| Gross Profit | ||||||||||||||
| Cost of Revenue |
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(3)
|
(2)
|
(2)
|
(3)
|
(2)
|
(3)
|
(6)
|
(10)
|
|
| Gross Profit |
13
N/A
|
13
-5%
|
10
-23%
|
9
-11%
|
11
+30%
|
11
-7%
|
11
+5%
|
13
+21%
|
14
+8%
|
17
+16%
|
20
+20%
|
20
-2%
|
19
-5%
|
|
| Operating Income | ||||||||||||||
| Operating Expenses |
(21)
|
(19)
|
(17)
|
(15)
|
(16)
|
(18)
|
(21)
|
(26)
|
(26)
|
(33)
|
(29)
|
(29)
|
(28)
|
|
| Selling, General & Administrative |
(18)
|
(15)
|
(14)
|
(12)
|
(13)
|
(14)
|
(17)
|
(22)
|
(22)
|
(22)
|
(23)
|
(22)
|
(20)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(3)
|
|
| Depreciation & Amortization |
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(1)
|
|
| Other Operating Expenses |
(3)
|
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(8)
|
(3)
|
(4)
|
(5)
|
|
| Operating Income |
(8)
N/A
|
(6)
+20%
|
(7)
-11%
|
(6)
+14%
|
(5)
+19%
|
(7)
-40%
|
(10)
-44%
|
(13)
-27%
|
(12)
+6%
|
(16)
-39%
|
(9)
+46%
|
(9)
+2%
|
(9)
-4%
|
|
| Pre-Tax Income | ||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
0
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
1
|
0
|
1
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Pre-Tax Income |
(8)
N/A
|
(6)
+21%
|
(7)
-15%
|
(5)
+28%
|
(5)
0%
|
(7)
-28%
|
(8)
-23%
|
(12)
-43%
|
(17)
-44%
|
(16)
+8%
|
(9)
+44%
|
(9)
+3%
|
(9)
-6%
|
|
| Net Income | ||||||||||||||
| Tax Provision |
1
|
1
|
(3)
|
(4)
|
1
|
1
|
1
|
1
|
2
|
1
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(7)
|
(6)
|
(10)
|
(9)
|
(4)
|
(6)
|
(7)
|
(11)
|
(15)
|
(14)
|
(9)
|
(9)
|
(9)
|
|
| Net Income (Common) |
(6)
N/A
|
(6)
+0%
|
36
N/A
|
37
+3%
|
(4)
N/A
|
(6)
-34%
|
(7)
-29%
|
(11)
-47%
|
(15)
-39%
|
(14)
+6%
|
(9)
+39%
|
(9)
+3%
|
(9)
-6%
|
|
| EPS (Diluted) |
-0.05
N/A
|
-0.04
+20%
|
0.24
N/A
|
0.25
+4%
|
-0.03
N/A
|
-0.04
-33%
|
-0.05
-25%
|
-0.07
-40%
|
-0.1
-43%
|
-0.08
+20%
|
-0.04
+50%
|
-0.04
N/A
|
-0.04
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
